NumerixS Investment Technologies’s Acadia Pharmaceuticals ACAD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q3 | – | Sell |
-11,501
| Closed | -$557K | – | 10 |
|
|
2020
Q2 | $557K | Buy |
11,501
+9,401
| +448% | +$455K | 0.16% | 149 |
|
|
2020
Q1 | $89K | Buy |
+2,100
| New | +$89K | 0.05% | 457 |
|
|
2019
Q4 | – | Sell |
-6,798
| Closed | -$245K | – | 1020 |
|
|
2019
Q3 | $245K | Buy |
6,798
+2,798
| +70% | +$101K | 0.06% | 329 |
|
|
2019
Q2 | $107K | Buy |
+4,000
| New | +$107K | 0.03% | 588 |
|
|
2018
Q3 | – | Sell |
-13,500
| Closed | -$203K | – | 1167 |
|
|
2018
Q2 | $203K | Buy |
13,500
+5,600
| +71% | +$84.2K | 0.05% | 518 |
|
|
2018
Q1 | $183K | Buy |
+7,900
| New | +$183K | 0.05% | 434 |
|
|
2017
Q4 | – | Sell |
-3,600
| Closed | -$136K | – | 1098 |
|
|
2017
Q3 | $136K | Buy |
+3,600
| New | +$136K | 0.03% | 643 |
|
|
2016
Q3 | – | Sell |
-6,086
| Closed | -$198K | – | 1087 |
|
|
2016
Q2 | $198K | Buy |
+6,086
| New | +$198K | 0.03% | 702 |
|
|
2015
Q2 | – | Sell |
-20,047
| Closed | -$653K | – | 611 |
|
|
2015
Q1 | $653K | Buy |
+20,047
| New | +$653K | 0.12% | 240 |
|